RLAY Q2 2025 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$677,000

Gross Profit

$677,000100.0% margin

Operating Income

-$77M-11351.1% margin

Net Income

-$70M-10395.1% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

-91.2%

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$55M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$729M

Total Liabilities

$63M

Stockholders' Equity

$666M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$677,000	$0	—
Gross Profit	$677,000	$0	—
Operating Income	-$77M	-$101M	+23.7%
Net Income	-$70M	-$92M	+23.7%

Revenue Segments

Operating Segments

$677,000100%